2026 RNDS | Updates in the CosMOG Trial @wearesrna
2026 RNDS | Updates in the CosMOG Trial  @wearesrna
Uploaded October 2026 | Updated November 2026, 3 hours ago
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Michael Levy, MD, PhD, of Massachusetts General Hospital, gave an update on the CosMOG trial, one of two large phase three trials in MOG antibody disease (MOGAD) [00:00:05]. He explained why preventing attacks matters and what people with a first MOGAD attack can expect [00:01:11]. He described how a MOGAD attack develops and how current medications act on different parts of the immune system [00:02:46]. Dr. Levy explained how the trial drug blocks FcRn so that antibodies are cleared faster, and how it compares with plasma exchange and IVIG [00:05:17]. He covered the trial design for people with relapsing MOGAD, in which everyone is allowed one attack before moving to open-label treatment, and said results may come by next year [00:10:29].

Michael Levy, MD, PhD, is an Associate Neurologist at Massachusetts General Hospital and Research Director of the Division of Neuroimmunology and Neuroinfectious Disease. He completed the MD/PhD program at Baylor College of Medicine and trained at Johns Hopkins, where he started the Neuromyelitis Optica Clinic and Research Laboratory. In 2019, he moved to Massachusetts General Hospital and Harvard Medical School to develop the research program in neuroimmunology.

00:00 Introduction
00:37 About the CosMOG Trial
01:11 Relapse Risk in MOGAD
01:45 Why Preventing Attacks Matters
02:46 How a MOGAD Attack Develops
04:14 How Current Medications Work
05:17 Blocking FcRn
07:53 How the Trial Began
08:53 Other MOGAD Trials
10:29 Trial Design
12:35 The Open-Label Phase and Safety
13:05 Where the Trial Stands
2026 RNDS | Updates in the CosMOG Trial2024 TM Together | Community Q&A2023 RNDS en Español | El Sistema nervioso y el Sistema inmune 1012026 RNDS | Rehabilitation in Rare Neuroimmune Disorders2026 RNDS | Fatigue, Sleep, and Cognition2025 RNDS | Research Updates2025 RNDS en Español | Preguntas y respuestas con los especialistas2023 RNDS | Cognition, depression, and rare neuroimmune disordersCommunity Meets Clinic 302. Drs. Grace Gombolay and Varun Kannan2026 RNDS | Day Two Kickoff: Quality of Life as a Clinical Outcome201. Steroid Dependence2024 RNDS | What’s my Diagnosis? Physician Panel Discussion Based on Community Panel Presentations
SRNA |

2026 RNDS | Updates in the CosMOG Trial

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER